A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura

Haematologica

Volumn 93, Issue 1, 2008, Pages 151-152

  Mittal, Sajjan ^a   Blaylock, Morgan G ^b   Culligan, Dominic J ^a   Barker, Robert N ^b   Vickers, Mark A ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

'CLL phenotype' lymphocytes; Autoimmune hemolytic anemia; Clonal B cells; Immune thrombocytopenic purpura

Indexed keywords

STEROID;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROL GROUP; FLOW CYTOMETRY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOSUPPRESSIVE TREATMENT; PATHOGENESIS; PHENOTYPE; PREVALENCE; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; CASE-CONTROL STUDIES; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTES; MIDDLE AGED; PHENOTYPE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SYNDROME;

EID: 38549115149     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11822     Document Type: Article

References (8)

1. Bottiger LE, Westerholm B. Acquired haemolytic anaemia. I. Incidence and aetiology. Acta Med Scand 1973;193:223-6.
2. Sallah S, Wan JY, Hanrahan LR. Future development of lymphoproliferative disorders in patients with autoimmune hemolytic anemia. Clin Cancer Res 2001;7:791-4.
3. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981;304:1135-47.
4. Hamblin, T. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Cheson BD, ed. Chronic Lymphoid Leukemias. New York: Marcel Dekker, 2001. p. 435-58.
5. Barcellini W, Montesano R, Clerici G, Zaninoni A, Imperiali FG, Calori R, et al. In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. Am J Hematol 2002;71:177-83.
6. Hall AM, Vickers MA, McLeod E, Barker RN. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood 2005;105:2007-15.
7. Rawstron AC, Kennedy B, Evans PA, Davies FE, Richards SJ, Haynes AP, et al. Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy. Blood 2001;98:29-35.
8. Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635-9.